rs150535071
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001271938.2(MEGF8):c.1902C>T(p.Cys634Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00174 in 1,599,034 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0090 ( 20 hom., cov: 32)
Exomes 𝑓: 0.00097 ( 22 hom. )
Consequence
MEGF8
NM_001271938.2 synonymous
NM_001271938.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.70
Publications
0 publications found
Genes affected
MEGF8 (HGNC:3233): (multiple EGF like domains 8) The protein encoded by this gene is a single-pass type I membrane protein of unknown function that contains several EGF-like domains, Kelch repeats, and PSI domains. Defects in this gene are a cause of Carpenter syndrome 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
MEGF8 Gene-Disease associations (from GenCC):
- MEGF8-related Carpenter syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- Carpenter syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 19-42344554-C-T is Benign according to our data. Variant chr19-42344554-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 540548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.7 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00903 (1375/152232) while in subpopulation AFR AF = 0.0312 (1298/41548). AF 95% confidence interval is 0.0298. There are 20 homozygotes in GnomAd4. There are 620 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MEGF8 | ENST00000251268.11 | c.1902C>T | p.Cys634Cys | synonymous_variant | Exon 11 of 42 | 5 | NM_001271938.2 | ENSP00000251268.5 | ||
| MEGF8 | ENST00000334370.8 | c.1902C>T | p.Cys634Cys | synonymous_variant | Exon 11 of 41 | 1 | ENSP00000334219.4 | |||
| MEGF8 | ENST00000378073.5 | c.-5184C>T | 5_prime_UTR_variant | Exon 11 of 41 | 5 | ENSP00000367313.4 |
Frequencies
GnomAD3 genomes AF: 0.00899 AC: 1368AN: 152114Hom.: 20 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1368
AN:
152114
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00238 AC: 550AN: 230950 AF XY: 0.00175 show subpopulations
GnomAD2 exomes
AF:
AC:
550
AN:
230950
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000971 AC: 1405AN: 1446802Hom.: 22 Cov.: 31 AF XY: 0.000851 AC XY: 613AN XY: 719946 show subpopulations
GnomAD4 exome
AF:
AC:
1405
AN:
1446802
Hom.:
Cov.:
31
AF XY:
AC XY:
613
AN XY:
719946
show subpopulations
African (AFR)
AF:
AC:
1114
AN:
33392
American (AMR)
AF:
AC:
89
AN:
44212
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
25958
East Asian (EAS)
AF:
AC:
1
AN:
39616
South Asian (SAS)
AF:
AC:
7
AN:
85900
European-Finnish (FIN)
AF:
AC:
0
AN:
42274
Middle Eastern (MID)
AF:
AC:
10
AN:
5526
European-Non Finnish (NFE)
AF:
AC:
53
AN:
1109892
Other (OTH)
AF:
AC:
127
AN:
60032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
77
155
232
310
387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00903 AC: 1375AN: 152232Hom.: 20 Cov.: 32 AF XY: 0.00833 AC XY: 620AN XY: 74434 show subpopulations
GnomAD4 genome
AF:
AC:
1375
AN:
152232
Hom.:
Cov.:
32
AF XY:
AC XY:
620
AN XY:
74434
show subpopulations
African (AFR)
AF:
AC:
1298
AN:
41548
American (AMR)
AF:
AC:
60
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5170
South Asian (SAS)
AF:
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1
AN:
67988
Other (OTH)
AF:
AC:
13
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
66
132
198
264
330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 05, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
MEGF8-related Carpenter syndrome Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.